Brooks Laboratories reports consolidated net loss of Rs 4.68 crore in the September 2022 quarter

HB Stockholdings Ltd, HOV Services Ltd, Bansal Roofing Products Ltd and Brooks Laboratories Ltd are among the other gainers in the BSE’s ‘B’ group today, 21 April 2022.

Capital Trust Ltd leads gainers in ‘B’ group

The company is engaged in manufacturing drugs and pharmaceuticals.

Brooks Laboratories’ subsidiary gets marketing authorization in Germany for Meropenem

Dynamatic Technologies Ltd, Jagsonpal Pharmaceuticals Ltd, Shemaroo Entertainment Ltd and Brooks Laboratories Ltd are among the other gainers in the BSE’s ‘B’ group today, 09 September 2021.

Raj Oil Mills Ltd leads gainers in ‘B’ group

Brooks Laboratories Ltd, Hindustan Fluoro Carbons Ltd, Shubham Polyspin Ltd and Essar Shipping Ltd are among the other losers in the BSE’s ‘B’ group today, 31 August 2021.

Gyscoal Alloys Ltd leads losers in ‘B’ group

After completing new investments of Rs. 74.5 Crores, SteriScience will have 51% of BSL, while Brooks will have the remaining 49% ownership.

Brooks Laboratories to make new investments in JV to build integrated global carbapenem biz

Brooks Laboratories reports standalone net loss of Rs 3.12 crore in the December 2020 quarter

The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.

BRIEF-Brooks Laboratories Re-Appoints Rajesh Mahajan As MD - Investing.com India

BRIEF-Brooks Laboratories Completes Formation Of Marketing JV With SteriScience - Investing.com India

Among the stocks that touched their 52-week highs were Aarti Drugs ,Banaras Beads , Akash Infra-Projects, Balkrishna Industries, Brooks Laboratories, Divi’s Laboratories, Emami, The Grob Tea Company, Essel Propack, Ester Industries, Jindal Stainless, Marksans Pharma, Mastek, Ndr Auto Components, Ka…

Share market update: 98 stocks hit 52-week highs on NSE

In pics | Stocks in the news: Maruti, Jubilant Lifesciences, Havells, Nestle India, Blue Star, Aurobindo Pharma

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Average profitability - not good, not bad

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Brooks Laboratories Ltd. is a Contract Manufacturing Company.  The Company manufacturers molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups. 